These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2833903)

  • 41. Ecto-nucleoside triphosphate pyrophosphohydrolase activity and calcium pyrophosphate dihydrate crystal deposition disease.
    Wortmann RL; Ryan LM; Karas B; McCarthy DJ
    Adv Exp Med Biol; 1986; 195 Pt A():153-6. PubMed ID: 3014830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of crystals in synovial fluids by light microscopy: sensitivity and reliability.
    Gordon C; Swan A; Dieppe P
    Ann Rheum Dis; 1989 Sep; 48(9):737-42. PubMed ID: 2478085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synovial fluid calcium pyrophosphate dihydrate crystals and alizarin red positivity: analysis of 3000 samples.
    Hamilton E; Pattrick M; Hornby J; Derrick G; Doherty M
    Br J Rheumatol; 1990 Apr; 29(2):101-4. PubMed ID: 2157516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arthropathies associated with calcium-containing crystals.
    McCarty DJ
    Hosp Pract (Off Ed); 1986 Oct; 21(10):109-15, 118-20. PubMed ID: 3020071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy.
    Martínez Sanchis A; Pascual E
    Ann Rheum Dis; 2005 Dec; 64(12):1769-72. PubMed ID: 15941838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies.
    Nalbant S; Martinez JA; Kitumnuaypong T; Clayburne G; Sieck M; Schumacher HR
    Osteoarthritis Cartilage; 2003 Jan; 11(1):50-4. PubMed ID: 12505487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical aspects of calcium pyrophosphate dihydrate crystal deposition.
    Doherty M; Dieppe P
    Rheum Dis Clin North Am; 1988 Aug; 14(2):395-414. PubMed ID: 2845493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium pyrophosphate deposition disease: clinical manifestations.
    Ferrone C; Andracco R; Cimmino MA
    Reumatismo; 2012 Jan; 63(4):246-52. PubMed ID: 22303531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium pyrophosphate dihydrate crystal deposition in neuropathic joints. Four cases of polyarticular involvement.
    Jacobelli S; McCarty DJ; Silcox DC; Mall JC
    Ann Intern Med; 1973 Sep; 79(3):340-7. PubMed ID: 4355953
    [No Abstract]   [Full Text] [Related]  

  • 50. Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout.
    Silcox DC; McCarty DJ
    J Lab Clin Med; 1974 Apr; 83(4):518-31. PubMed ID: 4361744
    [No Abstract]   [Full Text] [Related]  

  • 51. Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis.
    Doherty M; Belcher C; Regan M; Jones A; Ledingham J
    Ann Rheum Dis; 1996 Jul; 55(7):432-6. PubMed ID: 8774160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conventional Radiology in Crystal Arthritis: Gout, Calcium Pyrophosphate Deposition, and Basic Calcium Phosphate Crystals.
    Jacques T; Michelin P; Badr S; Nasuto M; Lefebvre G; Larkman N; Cotten A
    Radiol Clin North Am; 2017 Sep; 55(5):967-984. PubMed ID: 28774457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inorganic pyrophosphate in metabolic diseases predisposing to calcium pyrophosphate dihydrate crystal deposition.
    Doherty M; Chuck A; Hosking D; Hamilton E
    Arthritis Rheum; 1991 Oct; 34(10):1297-303. PubMed ID: 1657004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The solubility of calcium pyrophosphate dihydrate crystals].
    Sakamoto H
    Nihon Seikeigeka Gakkai Zasshi; 1995 Jul; 69(7):484-92. PubMed ID: 7561350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wrist arthropathy in calcium pyrophosphate dihydrate deposition disease.
    Utsinger PD; Resnick D; Zvaifler NJ
    Arthritis Rheum; 1975; 18(5):485-91. PubMed ID: 172092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of calcium pyrophosphate crystal arthritis and basic calcium phosphate crystal arthropathy.
    Abhishek A; Doherty M
    Rheum Dis Clin North Am; 2014 May; 40(2):177-91. PubMed ID: 24703342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synovial fluid analysis.
    Pascual E; Jovaní V
    Best Pract Res Clin Rheumatol; 2005 Jun; 19(3):371-86. PubMed ID: 15939364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal deposition disease of the shoulder (including calcific tendonitis and milwaukee shoulder syndrome).
    Halverson PB
    Curr Rheumatol Rep; 2003 Jun; 5(3):244-7. PubMed ID: 12744818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium pyrophosphate crystal deposition in model systems.
    Mandel N; Mandel G
    Rheum Dis Clin North Am; 1988 Aug; 14(2):321-40. PubMed ID: 2845492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nail-patella syndrome associated with mixed crystal deposition arthropathy.
    Papadakos VT; Swan A; Bhalla AK
    Clin Rheumatol; 1992 Sep; 11(3):413-5. PubMed ID: 1333935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.